• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

mSphere . Temporal Dynamics and Evolution of SARS-CoV-2 Demonstrate the Necessity of Ongoing Viral Genome Sequencing in Ontario, Canada

tetano

Editor, Senior Moderator
mSphere


. 2021 May 5;6(3):e00011-21.
doi: 10.1128/mSphere.00011-21.
Temporal Dynamics and Evolution of SARS-CoV-2 Demonstrate the Necessity of Ongoing Viral Genome Sequencing in Ontario, Canada


Calvin P Sjaarda[SUP] 1 2 [/SUP], Jennifer L Guthrie[SUP] 3 [/SUP], Samira Mubareka[SUP] 4 5 [/SUP], Jared T Simpson[SUP] 6 7 [/SUP], Bettina Hamelin[SUP] 8 [/SUP], Henry Wong[SUP] 9 [/SUP], Leanne Mortimer[SUP] 10 11 12 [/SUP], Robert Slinger[SUP] 12 13 [/SUP], Andrew G McArthur[SUP] 14 15 16 [/SUP], Marc Desjardins[SUP] 10 17 [/SUP], Allison McGeer[SUP] 18 19 [/SUP], Tony Mazzulli[SUP] 3 5 18 [/SUP], Katya Douchant[SUP] 20 [/SUP], Danielle Brabant-Kirwan[SUP] 21 [/SUP], Ramzi Fattouh[SUP] 22 [/SUP], Aaron Campigotto[SUP] 5 23 [/SUP], Samir N Patel[SUP] 3 5 [/SUP], Nahuel Fittipaldi[SUP] 3 5 19 [/SUP], Robert I Colautti[SUP] #[/SUP][SUP] 24 [/SUP], Prameet M Sheth[SUP] #[/SUP][SUP] 9 20 25 26 [/SUP]



Affiliations

Abstract

Genome-wide variation in SARS-CoV-2 reveals evolution and transmission dynamics which are critical considerations for disease control and prevention decisions. Here, we review estimates of the genome-wide viral mutation rates, summarize current COVID-19 case load in the province of Ontario, Canada (5 January 2021), and analyze published SARS-CoV-2 genomes from Ontario (collected prior to 24 November 2020) to test for more infectious genetic variants or lineages. The reported mutation rate (?10[SUP]-6[/SUP] nucleotide [nt][SUP]-1[/SUP] cycle[SUP]-1[/SUP]) for SARS-CoV-2 is typical for coronaviruses. Analysis of published SARS-CoV-2 genomes revealed that the G614 spike protein mutation has dominated infections in Ontario and that SARS-CoV-2 lineages present in Ontario have not differed significantly in their rate of spread. These results suggest that the SARS-CoV-2 population circulating in Ontario has not changed significantly to date. However, ongoing genome monitoring is essential for identification of new variants and lineages that may contribute to increased viral transmission.

Keywords: COVID-19; G614D; PANGOLIN lineage; SARS-CoV-2; epidemiology; genetics; infectious disease; public health.
 
Back
Top Bottom